Tailoring viral clearance study design to development phase, modality, and regulatory requirements
Kathleen Kenney
05 November 2025
Register
Peptone supplementation to increase productivity and reduce serum use in vaccine manufacturing
Syed Muaz Khalil, Chris Titensor
07 October 2025
Watch
Vaccine wastage through a new lens: improving estimates through analytics
Laila A Akhlaghi, Wendy Prosser
03 October 2025
Commentary
Building manufacturing efficiency in early process development: challenges and opportunities
Yan-Ping Yang, Tony D'Amore
30 September 2025
Expert Insight
Building sustainable, forward-looking immunization programs: lessons from Rwanda
Hyacinthe Mushumbamwiza
23 September 2025
Viewpoint
Science that serves: building sustainable vaccine clinical research capacity in Malawi and the UK
Stephen Gordon
23 September 2025
Interview
Vaccine World Asia Congress 2025—South East Asia
16 September 2025
Event Preview
World Vaccine Congress Europe 2025
15 September 2025
Event Preview
De-risking Phase I/II trials for emerging biotech innovators
J Gordon, L Timmerman, D Schaumberg et al
09 September 2025
Watch
Biologics CDMO Europe 2025
08 September 2025
Event Preview
Next-generation potency tests for whole cell pertussis vaccines
Y Adewunmi, J Doering, L Viviani et al
05 September 2025
Expert Insight
Sustainable vaccine development and production in Africa: the role of policy and regulatory frameworks in advancing local manufacturing
A Ashie, F Nabonasi, G Sabblah et al
28 August 2025
Commentary
Building long-term vaccine manufacturing capacity for the world: a framework for sustainable development in LMICs
Salome Magalhaes, Eli Keshavarz-Moore
11 August 2025
Review
Key considerations around the decision to localize vaccine manufacture in LMIC countries
Kristopher Howard
04 August 2025
Interview
Pioneering technological innovation and sustainability in vaccine manufacturing to ensure pandemic preparedness and global access
A Tacu, M Micheletti, S Morris et al
29 July 2025
Commentary
Microphysiological systems for use in vaccine potency assays
Todd Ranheim
17 July 2025
Viewpoint
Controlled human infection models in vaccine development: what’s new in 2025?
M B Laurens, A P Durbin, M Cavaleri et al
07 July 2025
Expert Roundtable
Personalized neoantigen cancer vaccines in the spotlight
J Yan, R Perales-Linares, N Cooch et al
03 July 2025
Review
Leveraging in silico tools to accelerate vaccine manufacturing: the promise of computational fluid dynamics and hybrid process models
I Meln, X Li, A Gaetano Cardillo et al
01 July 2025
Viewpoint
Patient-centric approaches to vaccine development
R Desikan, C Campa, M Fourneau et al
27 June 2025
Expert Roundtable
Building trust in vaccines: why emotions are as important as facts
Stephen Hughes
23 June 2025
Interview